drugset
drugset / Trial / NCT00345202

Short Term Effects of HMG-CoA Reductase Inhibition (Atorvastatin)on Renal Hemodynamics, Tubular Function and Vasoactive Hormones on Healthy Subjects

NCT00345202 ↗

Phase 4 Completed 20 enrolled Regional Hospital Holstebro
RandomizedCrossoverDouble-blind

Summary

We wanted to test the shortterm effects of HMG-CoA reductase inhibition (atorvastatin) on renal hemodynamics, renal tubular function and vasoactive hormones on healthy subjects.

Timeline

Start
2004-09
Primary completion
2005-02
Completion
2005-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule — —

Indications

No indication recorded.